Sangiovanni Timothy J. 4
4 · KEMPHARM, INC · Filed Mar 16, 2020
Insider Transaction Report
Form 4
KEMPHARM, INCKMPH
Sangiovanni Timothy J.
SVP, Finance & Corp Controller
Transactions
- Purchase
Common Stock
2020-03-13$0.20/sh+4,000$800→ 18,000 total
4 · KEMPHARM, INC · Filed Mar 16, 2020
Common Stock